966 results

1. pENN.AAV.CMVs.Pl.Cre.rBG (AAV8)

   Viral Prep

   #105537-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   None

   Available since

   Dec. 14, 2018

   Availability

   Academic Institutions and Nonprofits only

2. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV1)

   Viral Prep

   #105677-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Ofer Yizhar

   Article

   Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

   Promoter

   Syn

   Tags

   FusionRed (Cre-dependent)

   Available since

   Aug. 17, 2018

   Availability

   Academic Institutions and Nonprofits only

3. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV8)

   Viral Prep

   #105530-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   EGFP

   Available since

   June 29, 2018

   Availability

   Academic Institutions and Nonprofits only

4. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV PHP.eB)

   Viral Prep

   #105530-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   EGFP

   Available since

   Feb. 16, 2024

   Availability

   Academic Institutions and Nonprofits only

5. pAAV.GfaABC1D.PI.Lck-GFP.SV40 (AAV5)

   Viral Prep

   #105598-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV.GfaABC1D.PI.Lck-GFP.SV40 (#105598). In addition to the viral particles, you will also receive purified pAAV.GfaABC1D.PI.Lck-GFP.SV40 plasmid DNA. GfaABC1D-driven GFP expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Baljit Khakh

   Article

   Shigetomi et al J Gen Physiol. 2013 Apr 15.

   Promoter

   GfaABC1D

   Tags

   GFP

   Available since

   March 8, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-EF1a-fDIO-Cre (AAV Retrograde)

   Viral Prep

   #121675-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Esteban Engel, Alexander Nectow

   Article

   Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30

   Promoter

   EF1a

   Tags

   None

   Available since

   May 31, 2019

   Availability

   Academic Institutions and Nonprofits only

7. pZac2.1 gfaABC1D-lck-GCaMP6f (AAV5)

   Viral Prep

   #52924-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pZac2.1 gfaABC1D-lck-GCaMP6f (#52924). In addition to the viral particles, you will also receive purified pZac2.1 gfaABC1D-lck-GCaMP6f plasmid DNA. gfaABC1D-driven (similar to GFAP promoter) lck-GCaMP6f calcium sensor expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Baljit Khakh

   Promoter

   Tags

   None

   Available since

   April 19, 2018

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV1)

   Viral Prep

   #26969-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CaMKIIa-hChR2(H134R)-EYFP (#26969). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-EYFP plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Lee et al Nature. 2010 Jun 10. 465(7299):788-92.

   Promoter

   CaMKII

   Tags

   EYFP

   Available since

   May 9, 2018

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-hSyn-EGFP (AAV2 trial size)

   Viral Prep

   #50465-AAV2.T

   Purpose

   Ready-to-use AAV2 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   EGFP

   Available since

   July 31, 2019

   Availability

   Academic Institutions and Nonprofits only

10. AiP13044 - pAAV-AiE0779m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3044) (AAV PHP.eB)

    Viral Prep

    #191706-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from AiP13044 - pAAV-AiE0779m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3044) (#191706). In addition to the viral particles, you will also receive purified AiP13044 - pAAV-AiE0779m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3044) plasmid DNA. SYFP2-expression in striatal direct pathway medium spiny neurons (D1-MSNs). These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jonathan Ting, The Allen Institute for Brain Science

    Article

    Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1

    Promoter

    Tags

    SYFP2

    Available since

    July 15, 2024

    Availability

    Academic Institutions and Nonprofits only